RenovoRx Announces Third Quarter 2021 Financial Results
RenovoRx today reported its unaudited financial results for the third quarter ended September 30, 2021.
RenovoRx Announces Third Quarter 2021 Financial Results
RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today reported its unaudited financial results for the third quarter ended September 30, 2021.